Macrophages are not the source of injurious interleukin-18 in ischemic acute kidney injury in mice

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 3, 2009, Pages

  He, Zhibin ^a   Dursun, Belda ^a   Oh, Dong Jin ^a   Lu, Lawrence ^a   Faubel, Sarah ^a   Edelstein, Charles L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Inflammation; Liposomal clodronate; NK cells; Tissue damage

Indexed keywords

CD11B ANTIGEN; CLODRONIC ACID; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOSOME; MESSENGER RNA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CONTROLLED STUDY; IMMUNOFLUORESCENCE; KIDNEY INJURY; KIDNEY ISCHEMIA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; STAINING; WILD TYPE;

ACUTE KIDNEY INJURY; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; CASPASE 1; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; INTERLEUKIN-18; KIDNEY; KILLER CELLS, NATURAL; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RNA, MESSENGER;

EID: 66049130202     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90634.2008     Document Type: Article

References (38)

1. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 12: 59-63, 2000. (Pubitemid 30093451)
2. Badgwell B, Parihar R, Magro C, Dierksheide J, Russo T, Carson WE III. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery 132: 205-212, 2002.
3. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 3: 409-413, 2007. (Pubitemid 46333828)
4. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485, 2004. (Pubitemid 38981982)
5. Cailhier JF, Partolina M, Vuthoori S, Wu S, Ko K, Watson S, Savill J, Hughes J, Lang RA. Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation. J Immunol 174: 2336-2342, 2005. (Pubitemid 40223983)
6. Carroll JL, Nielsen LL, Pruett SB, Mathis JM. The role of natural killer cells in adenovirus-mediated p53 gene therapy. Mol Cancer Ther 1: 49-60, 2001.
7. Cugini D, Azzollini N, Gagliardini E, Cassis P, Bertini R, Colotta F, Noris M, Remuzzi G, Benigni A. Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. Kidney Int 67: 1753-1761, 2005. (Pubitemid 40577710)
8. Daemen MA, Van't Veer C, Wolfs TG, Buurman WA. Ischemia-reperfusion- induced IFN-gamma upregulation: involvement of IL-12 and Il-18. J Immunol 162: 5506-5510, 1999.
9. Day YJ, Huang L, Ye H, Linden J, Okusa MD. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of macrophages. Am J Physiol Renal Physiol 288: F722-F731, 2005. (Pubitemid 40381739)
10. De Greef KE, Ysebaert DK, Dauwe S, Persy V, Vercauteren SR, Mey D, De Broe ME. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 60: 1415-1427, 2001. (Pubitemid 32960035)
11. Dinarello CA. Targeting interleukin 18 with interleukin 18 binding protein. Ann Rheum Dis 59, Suppl 1: i17-i20, 2000.
12. Dinarello CA. Novel targets for interleukin 18 binding protein. Ann Rheum Dis 60, Suppl 3: iii18 -iii24, 2001.
13. Dursun B, He Z, Somerset H, Oh DJ, Faubel S, Edelstein CL. Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosis. Am J Physiol Renal Physiol 291: F578-F587, 2006. (Pubitemid 44343739)
14. Edelstein CL, Schrier RW. Pathophysiology of ischemic acute renal injury. In: Diseases of the Kidney and Urinary Tract, edited by Schrier RW. Philadelphia, PA: Lippincott, Williams and Wilkins, 2007, p. 930-961.
15. Edelstein CL, Hoke TS, Somerset H, Fang W, Klein CL, Dinarello CA, Faubel S. Proximal tubules from caspase-1 deficient mice are protected against hypoxia-induced membrane injury. Nephrol Dial Transplant 22: 1052-1061, 2007. (Pubitemid 46523418)
16. Fabian MC, Lakey JR, Rajotte RV, Kneteman NM. The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies. Transplantation 56: 1137-1142, 1993.
17. Fantuzzi G, Banda NK, Guthridge C, Vondracek A, Kim SH, Siegmund B, Azam T, Sennello JA, Dinarello CA, Arend WP. Generation and characterization of mice transgenic for human IL-18-binding protein isoform a. J Leukoc Biol 74: 889-896, 2003. (Pubitemid 38040365)
18. Faubel SG, Ljubanovic D, Poole B, Dursun B, Cushing S, He Z, Gill RG, Edelstein CL. Peripheral CD4 T cell depletion is not sufficient to prevent ischemic acute renal failure. Transplantation 80: 643-649, 2005. (Pubitemid 41377752)
19. Fortier AH, Falk LA. Isolation of murine macrophages. In: Current Protocols in Immunology, edited by Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, and Strober W. Hoboken, NJ: John Wiley and Sons, 2001.
20. Friedwald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 66: 486-491, 2004. (Pubitemid 38981983)
21. Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y, Tomosugi N, Mukaida N, Matsushima K, Egashira K, Yokoyama H. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol 14: 1066-1071, 2003. (Pubitemid 36359289)
22. He Z, Altmann C, Hoke TS, Ljubanovic D, Jani A, Dinarello CA, Faubel S, Edelstein CL. Interleukin-18 (IL-18) binding protein transgenic mice are protected against ischemic AKI. Am J Physiol Renal Physiol 295: F1414-F1421, 2008.
23. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 22: 5910-5919, 2002. (Pubitemid 35387635)
24. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK. Macrophages contribute to the initiation of ischemic acute renal failure in rats. Nephrol Dial Transplant 21: 1231-1239, 2006.
25. Jose MD, Ikezumi Y, Van Rooijen N, Atkins RC, Chadban SJ. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 76: 1015-1022, 2003. (Pubitemid 37280827)
26. Kanai T, Watanabe M, Okazawa A, Sato T, Hibi T. Interleukin-18 and Crohn's disease. Digestion 63, Suppl 1: 37-42, 2001.
27. Lochner M, Forster I. Anti-interleukin-18 therapy in murine models of inflammatory bowel disease. Pathobiology 70: 164-169, 2002.
28. Melnikov VY, Ecder T, Fantuzzi G, Siegmund B, Lucia MS, Dinarello CA, Schrier RW, Edelstein CL. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107: 1145-1152, 2001. (Pubitemid 32422911)
29. Melnikov VY, Faubel SG, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 110: 1083-1091, 2002. (Pubitemid 35215889)
30. Miura M, Fu X, Zhang QW, Remick DG, Fairchild RL. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 159: 2137-2145, 2001. (Pubitemid 33104268)
31. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2: 957-964, 2002. (Pubitemid 37323216)
32. Muhlen KA, Schumann J, Wittke F, Stenger S, Van Rooijen N, Van Kaer L, Tiegs G. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J Immunol 172: 3034-3041, 2004. (Pubitemid 38263692)
33. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12: 53-72, 2001. (Pubitemid 32294587)
34. Oh DJ, Dursun B, He Z, Lu L, Hoke TS, Ljubanovic D, Faubel S, Edelstein CL. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 294: F264-F271, 2008.
35. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10: 259-264, 1998. (Pubitemid 28286951)
36. Pomerantz BJ, Reznikov LL, Harken AH, Dinarello CA. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci USA 98: 2871-2876, 2001.
37. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174: 83-93, 1994. (Pubitemid 24297139)
38. Wu H, Craft ML, Wang P, Wyburn KR, Chen G, Ma J, Hambly B, Chadban SJ. IL-18 contributes to renal damage after ischemia-reperfusion. J Am Soc Nephrol 19: 2331-2341, 2008.